MetaCap

Penumbra Inc. Company Profile

NYSE: PENHealth CareMedical/Dental InstrumentsUSD

316.35-0.70 (-0.22%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Penumbra at a glance

Penumbra Inc. (NYSE: PEN) is a Medical/Dental Instruments company in the Health Care sector headquartered in Alameda, CA. Penumbra is led by Mr. Adam Elsesser J.D. and employs about 4,700 people. The company's shares have traded publicly since 2015.

At a market capitalization of $12.49 billion, it is considered a large-cap company. Its SEC Central Index Key (CIK) is 0001321732, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Penumbra do?

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Business description based on the company's public filings.

Company information

Legal name
Penumbra Inc.
Ticker
NYSE: PEN
Industry
Medical/Dental Instruments
CEO
Mr. Adam Elsesser J.D.
Employees
4,700
Headquarters
One Penumbra Place, Alameda, CA, United States
Phone
510 748 3200
IPO year
2015
Market cap
$12.49B
SEC CIK
0001321732
Latest annual report
10-K · Feb 25, 2026

Companies similar to Penumbra

PEN peer companies
CompanyPrice% ChgMarket capCompare
BAXBaxter International Inc.23.97-1.60%$12.39Bvs PEN
SOLVSolventum Corporation85.88-1.33%$14.62Bvs PEN
GKOSGlaukos Corporation172.18+6.55%$10.16Bvs PEN
GMEDGlobus Medical Inc. Class A73.75-3.51%$9.90Bvs PEN
PODDInsulet Corporation134.36-0.27%$9.32Bvs PEN
MMEDMiniMed Group Inc.19.11-2.70%$5.38Bvs PEN
STVNStevanato Group S.p.A.19.44-2.11%$5.31Bvs PEN
TFXTeleflex Incorporated124.48-0.21%$5.27Bvs PEN

Related